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1. Introduction 
Sepsis is a common disease in the domain of Critical Care Medicine. It is a systemic 
inflammatory response syndrome (SIRS), which is response to infection. And severe sepsis 
may lead to septic shock and multiple organ dysfunction syndrome (MODS). The 
pathogenesy underlying cardiac dysfunction in sepsis is still incompletely understood and 
the mortality is high, although considerable effort has been applicable to understand the 
mechanism of inflammatory cascade response and multiple-system organ failure induced by 
sepsis (Wheeler and Bernard 1999). The research also found that the incidence rates of 
severe sepsis in the patients of hospitalization were annualized increase by 8.7 percent in the 
United States in the past decades years ago (Bernard et al. 1997; Martin et al. 2003; Melamed 
and Sorvillo 2009). However the mortality decreased in a certain, from 27.8 percent 1979 to 
17.9 percent in 1995 (Martin et al. 2003; Melamed and Sorvillo 2009). But in the ICUs, 
incidence rate of severe sepsis occurs was still high which is up to 11% of the patients, and 
the mortality rates range from 18% to 55% in the developed country (Finfer et al. 2004; 
Karlsson et al. 2007). 
2. Septic cardiac dysfunction 
Defective cardiac function often occurs during sepsis, and it has been regarded as 
“cardiomyopathy of sepsis” (Niederbichler et al. 2006). The cardiac dysfunction greatly 
contributes to the the occurrence of sepsis shock and MODS in the sepsis patients. Decrease 
of the cardiac output can lead to hypoperfusion of the vital organs, the supply of oxygen 
and nutrition in tissue is reducing, the immunity is suppressed, and then the organs 
dysfunction happens (Kumar, Haery and Parrillo 2000). 
3. The pathogenesy of septic cardiac dysfunction 
Our understanding of septic cardiac dysfunction is ever more clear following the more and 
more studies on it. Early researches had revealed that myocardium intake 70%-75% oxygen 
from the coronary artery, and then saturation of blood oxygen in the coronary artery is only 
remains 25%-35%. In this situation when the need of the myocardium increase, ever more 
oxygen can’t get from the blood of the coronary artery. Under this circumstances, 
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myocardium want to intake ever more oxygen only through increasing blood flow of the 
coronary artery (Messer and Neill 1962). Based on this theory, early researchers assumed 
that myocardial depression and myocardial ischemia are interrelated during the septic 
shock. However, 1986 Cunnion et al (Cunnion et al. 1986) discovered that the relation 
between myocardial depression and decrease of the blood flow in the coronary artery is not 
obvious. We review almost recently researches and found out septic cardiac dysfunction 
may refer to following factors. 
3.1 Effect of circulating causative factors such as IL-1, TNF-α, HSP-70 in the progress 
of myocardial depression in sepsis 
Recently related review refered to the importance of pro-inflammatory cytokines and 
inflammatory protein in the septic cardiac dysfunction. These mediator are IL-1, TNF-ǂ, 
C5a, CRP, HSP70, myocardial depressant factor (MDF), NO, epinephrine, endothelin and so 
on (Cohen 2002; Grocott-Mason and Shah 1998; Price et al. 1999; Sharma 2007; Tracey 2002). 
IL-1 and TNF-ǂ are the most importance pro-inflammatory factors in the early stage of 
sepsis, and play a important in “cytokine storm” which the injury or endotoxin induces 
(Dinarello 1997; van der Poll and van Deventer 1999). Then the pleiotropic transcription 
factor NF-κB is activated and involves in the regulation of multiple biological phenomena, 
including stress response, cell growth, apoptosis, innate immunity, septic shock and so on 
(Brown and Jones 2004). 
3.2 Cytopathic hypoxia and oxidative stress damage may be the causative factors of 
myocardial depression in sepsis 
Evidence indicates that mitochondria is the energy plant of the cell metablism, it plays a 
critical role in oxygen utilization of cells and is responsible for supplying 90% ATP which 
the cell needed (Rolfe and Brown 1997). Redox-stimulated production of reactive oxygen 
species (ROS) may be one of the pathophysiologic mechanisms of sepsis. In that reactive 
oxygen may be through direct damage nucleotide of mitochondria then the DNA replication 
can be affected and the oxygen consumption can be reduced. 
In the cecal ligation and puncture (CLP) animal models, through intraperitoneally 
administrating with or without polyethylene glycole-catalase: PEG-CAT (H2O2 and O2– 
radical scavenger) 4 hours after CLP. Hirata discovered that the level of caspase-3, OGG1 in 
the former is significantly higher than the later, however, 8-Oxo-2'-deoxyguanosine ( 8-oxo-
dG), Coenzyme (Co)Q1/CoQ1H2 and Cytochrome C are significantly lowered. Thus he 
realized oxidative stress may make the mitochondria DNA and the respiratory chain 
especially the complex II damaged. And it is the major causative factor of mitochondria 
dysfunction (Hirata 2009). In the other hand, Ritter et al (Ritter et al. 2003) found out the 
ratio of superoxide dismutase (SOD) to hydrogen peroxidase was increasing. As known that 
SOD mainly catalyze the production of H2O2 and O2- and then make cell damaged. IL-1ǃ 
and TNF-ǂ may be the potential factors of the ratio imbalance (Schulze-Osthoff et al. 1992). 
All of these oxygen free radical can damage mitochondria and then damage the tissue and 
organs (Exline and Crouser 2008). Thus oxidative stress can damage mitochondria, decrease 
oxygen utilization of cell then lead to relative hypoxia. 
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3.3 The changes of expression of inflammation, energy metabolism and contractile 
related genes have been shown to be effective in the progress of septic cardiac 
dysfunction 
In animal experiment, the differences in gene expression of cardiac tissue in septic rats was 
detected, which is under the CLP, by DNA microarrays. Y Liu et al (Y Liu et al. 2009) has 
found out Ace gene showed up-regulation may increase expression of Ang I, so that they 
elucidated Ace may play an important in pro-inflammatory reaction during sepsis. 
Available evidence suggests that Ace can activate renin-angiotensin system, increase the 
level of leucocyte and dose-dependently increased the poorer outcome of sepsis (Danser et 
al. 1995; Westendorp et al. 1997). A recent study demonstrated angiotensin II stimulation 
can increase the chemokine monocyte chemoattractant protein-1 (MCP-1) expression in 
vascular smooth muscle cells (SMCs) of rats so as to act as pro-inflammatory role 
(Hernandez-Presa et al. 1997). At the same time, another study verified this inference from 
the reverse side. The local concentrations of nitric oxide may be raised by the lower Ace 
enzyme activity with the II genotype, and then may make the efficiency of mitochondrial 
respiration better (Borutaite et al. 2001). Thus contractile function can be improved in both 
cardiac and skeletal muscle. In addition, angiotensin-converting enzyme inhibitor (ACEI) 
can reduce the level of MCP-1 induced by Angiotensin II, which in turn interfering with 
CD4+ T cell proliferation and cytokine production mediated by MCP-1, so as to play anti-
inflammatory effects (Hogaboam et al. 1998). Thus the pro-inflammatory effects of the Ace 
may be proved from the other side. What is more, our research team discovered that down 
regulation of intracellular corticosteroid receptor gene NR1D1 expression may be an 
important factor in septic cardiac dysfunction animal experiments. Overexpression of NF-κB 
induced by the pro-inflammatory cytokines such as IL-1b, Osmr, maybe the cause (Y Liu et 
al. 2009). Down regulation of NR1D1 expression makes the function of glucocorticoid 
receptor (GCR) changed, and the number decreased, so that it makes septic rats insensitive 
to the anti-inflammatory action of GCs (Rook et al. 2000). In addition, up-regulation of G-
protein coupled receptor protein signaling transduction related gene (Gpr88) may be 
harmful to the heart. Because G-protein coupled receptor protein signaling pathway may 
along with the classic TPK signal transduction pathways to take part in signaling 
transduction of the heart tissue. Moreover up-regulation of transcription related gene 
(Cebpb) implies  CCAAT/enhancer-binding protein beta (C/EBPǃ) may play an important 
part in sepsis(Y Liu et al. 2009). In 2010, through researching in nitric oxide synthase (NOS) 
gene -/- rats, Dos Santos C C et al (dos Santos et al. 2010) discovered that rats of NOS -/-  
group failed to down-regulate the level of bioenergy and metabolism related genes 
expression such as PEX11b, PEX19 and PEX3 and PGC-1ǂ-related genes. So they regarded 
inducible nitric oxide synthase may be the cause of sepsis-induced myocardial depression. 
4. The micro-characterization of septic heart tissue 
As to the micro-characterization of septic heart tissue, inner and outer membranes of 
mitochondria was discovered patchily disrupted by electron microscopy (Suliman et al. 
2004). In this experiments, electron-lucent matrix, distorted cristae and variable swelling 
were found in the rat heart (Suliman et al. 2004). Also, in the rats experiments, Tatsumi et al 
(Tatsumi et al. 2004) has the similar findings. Compare to the sham group, there was less 
electron density in the mitochondria of septic hearts (Watts et al. 2004). In addition, 
autophagy was presented in the hearts of CLP animals by examination of electron 
micrographs (Watts et al. 2004). 
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5. The research progress of effect of the Ulinastatin (UTI) on septic cardiac 
dysfunction 
Rcently years UTI as endogenous inhibitor has obvious effect on inhibiting various prolease. It 
maybe an effective therapeutic drug on sepsis cardiac dysfunction. From it was discovered to 
now, it has been commonly used in patients with inflammatory disorders including sepsis, 
surgery, disseminated intravascular coagulation, shock, pancreatitis and so on. As a 
reasonable and effective drug is mainly used in China, Japan, Korea. Research also suggests 
that UTI may suppress the expression of various inflammatory factors above mentioned.  
Ulinastatin is a kind of serpin with 2 Kunitz-type domains, can inhibit the over expression of 
pro-inflammatory cytokines and then prevent subsequent organ failure induced by injuring 
or bacterial endotoxin. It was from human urine, as a urinary trypsin inhibitor, was 
described by Astrup T in 1964 (Astrup and Nissen 1964). It take part in regulating the 
physiological responses in the blood such as blood clotting response, complement 
activation, inflammation and so on to keep balance of internal environment. As for its 
protection role to septic cardiac depress maybe involve in the following aspects. 
5.1 Inhibit releasing of IL-1 to act as protective action  
Interleukin (IL)-1, a fever inducing substance secreted by activated leukocytes which lies at 
the center of the inflammatory response, was originally reported in the 1940s (Atkins 1960). 
It has two sub unites that are IL-1ǂ and IL-1ǃ. They have major roles in pro-inflammatory 
activities and host responses to not only exogenous but also endogenous noxious stimuli. 
Certainly these effects are contribute to the clearance of bacteria. However, in some cases 
these effects are detrimental, such as in serious septic shock and septic MODS (Miller et al. 
2006). The mechanism of the pro-inflammatory response is as follows( Ninomiya-Tsuji et al. 
1999). IL-1 binds to IL-1RI to form a complex protein associated with IL-1, then induces 
myeloid differentiation primary response gene 88 (MyD88) and the  IL-1R–associated kinase 
(IRAK) recruitment to its receptor. And then IRAK dissociates from IRAK-receptor complex 
and interacts with tumour-necrosis factor  receptor-associated factor 6 (TRAF6). Activated 
TRAF6 can make IL-1 signal transmit to the NF-kB-inducing kinase Ik B a/b ( NIK-IKK-a/b) 
kinase pathway (Cao, Henzel and Gao 1996; Cao et al. 1996; Wesche et al. 1997). 
Interestingly, TNF receptor associated factor 6 (TRAF6) may activate both Jun N-terminal 
kinase (JNK) and NF-κB pathway (Song et al. 1997). Of course, the mechanism is different. 
That is NIK is the key mediators of IL-1-mediated NF-κB activation (Karin and Delhase 
1998; Song et al. 1997). TAK1 can activate JNK pathway (Moriguchi et al. 1996; Shirakabe et 
al. 1997; Yamaguchi et al. 1995). However, TAK1 can be activated by TAB1 
protein(Ninomiya-Tsuji et al. 1999). At last NIK ± IKK cascade storm happens under the 
regulation of IL-1 signal pathway. Moreover, evidence also showed that under 
administration of LPS, the level of the mRNA for leptin in adipose tissue can be increased by 
IL-1 or TNF-a (Grunfeld et al. 1996). It was known that leptin not only through decreasing 
food intake, but also increasing energy expenditure via activation of the autonomic nervous 
system to regulate energy balance (Pelleymounter et al. 1995). Thus IL-1 not only regulates 
inflammatory reaction but also energy metabolism. However protein levels of IL-1b in the 
liver is significantly greater in UTI -/- than in normal WT mice after LPS challenge under the 
administration of UTI (Takano et al. 2009). So UTI may play an important part in inhibiting 
the expression of IL-1. 
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5.2 Inhibit releasing of IL-6 to act as protective action 
The level of IL-6 is an sensitive marker of tissue damage, and directly related to endotoxin 
production of the infectious diseases. It is commonly known that endotoxin is an important 
element of activated complement and cytokine which the inflammatory reaction related and 
may be an important factor of systemic inflammatory response syndrome (SIRS) (Pallua, 
Low and von Heimburg 2003). In addition, IL-6 as a endogenous pyrogen can stimulate 
body to generate neutrophil elastase and take part in pathophysiological process of sepsis 
and acute respiratory distress syndrome (ARDS) (Inoue et al. 2009). Pathan, N. et al (Pathan 
et al. 2004) found out the level of IL-6 was positively correlated to the degrees of cardiac 
suppression and plays a central role in cardiac suppression induced by bacterial infection. 
At the same time, in order to confirm this discovery, their research team verified this effect 
in the septic rat model with recombinant IL-6. However, Park, J. H. et al (Park et al. 2010a) 
found out UTI can reduce the level of stress reaction related cytokine such as IL-6 during 
gastrointestinal operation, also in the trauma patients with hemorrhagic shock has the 
similar discovery (Park et al. 2010b). This function was also verified by the septic rat model 
(Cao et al. 2010). Thus, UTI may regulate the level of IL-6 to act as anti-inflammatory role. 
5.3 Inhibit releasing of IL-8 to act as protective action 
It is well known that IL-8, a major mediator for neutrophil-mediated cell and tissue injury, is 
a member of C-X-C cytokine family. It is secreted by macrophages, epithelial cells and other 
cell types included. As a pro-inflammatory factor, it can through enhancing neutrophil 
infiltration, releasing of lysosomal enzyme and generating of superoxide anions, then 
induce tissue damage (Sekido et al. 1993). Kurt, A. N. et al (Kurt et al. 2007) found out the 
level of serum IL-8 in the patients with positive blood culture was found elevated 
significantly more than negative ones. It was also reported that UTI, as a broad-spectrum 
anti-inflammatory substance, may significantly down-regulate the production of IL-8 (Cao 
et al. 2010). Bae, H. B. et al (Bae et al. 2011) discovered the level of IL-8 in the UTI 
preconditioning sepsis rats is significantly lower than those in sepsis rats without treatment, 
and associated pathological section, they hold the opinion that UTI may through inhibiting 
IL-8 and so on mediators of inflammation in septic rats to act as a protective role in the 
septic process. Also there is evidence which shows that UTI can suppress the expression of 
IL-8 in vitro (Nakamura et al. 1997) 
5.4 Inhibit releasing of TNF-α to act as protective action 
Serum TNF-ǂ is secreted by the activated macrophage. Its relative molecular weight is 
17000. It can stimulate other inflammatory cytokine production and inflammatory cells into 
tissue (Cohen 2002). Also it acts as activator of the local and systemic inflammatory 
response, and its local accumulation can cause cardiovascular clinical symptoms, such as 
fever, swelling, pain and congestion. In vivo overall increase of the amount of TNF-ǂ can 
decrease cardiac output, and then mediates tissue injury, such as formation of micro-
thrombus and systemic capillary leak syndrome. As to regulating molecular pathway of the 
ischemia-reperfusion, TNF-ǂ maybe one of the most significant factors (Niemann, Garner 
and Lewis 2004; Toledo-Pereyra et al. 2004). At the same time, TNF-ǂ can also through 
activating other related cells secret cytokine such as IL-1, HMGB1, eicosanoids, NO, and 
reactive oxygen to enhance the role of inflammatory reaction and make this effect longer 
www.intechopen.com
 
The Transmission Electron Microscope 280 
(Tracey 2002). Thus it makes the tissue damage severely. It was found that serum TNF-ǂ 
significantly elevated during the septic systemic inflammatory response syndrome (SIRS) 
(Kurt et al. 2007). In all , TNF-ǂ can promote occurrence and development of the sepsis, the 
level of TNF-ǂ increasing can lead to cell death, apoptosis, and several organs dysfunction 
(Niemann, Garner and Lewis 2004). Thus it is very important to inhibit the release of TNF. 
In the recently years, study found out UTI may significantly reduce the level of TNF-ǂ to 
protect the tissue and organ during sepsis (Cao et al. 2010). Also a Japanese research team 
verify above conclusion in the other side, they found out in the pathogenesis of post-
resuscitation syndrome, insufficient production of UTI for norepinephrine (NE) releasing, 
accompanied by persistent high TNF-ǂ levels (Hayakawa et al. 2008). More over in vitro UTI 
can inhibit the release of TNF-a (Aosasa et al. 1998). In addition, in the liver injured animal 
model experiment also found the UTI can protect against severe liver injury through the 
suppression of TNF-a production(Takano et al. 2009). What is more, other scholar hold the 
opinion that UTI may reduce the NF-κB activation and then subsequently inhibit the 
expression of TNF-ǂ , CXC-chemokines and vascular endothelial cell adhesion molecules to 
protect hepatic cells against  ischemia and reperfusion( I/R) injury (Wu et al. 2009).  
5.5 To decrease the level of Nitric oxide(NO) expression  
The iNOS has been shown to be induced by mediators associated with sepsis, that is IL-1b, 
IL-2, IL-6, TNF and so on the pro-inflammatory cytokines and interferon endotoxin, and 
then increases production of NO in vitro (Nathan and Xie 1994). Early in 1991, there was 
evidence showed that NO synthase may play an important in the pathogenesis of septic 
shock and supressing activity of NO synthase may be a novel therapeutic option (Nathan 
1992; Petros, Bennett and Vallance 1991). Recently, in several experimental models, research 
indicated that overproduction of NO under the regulation of cytokine-inducible NOS 
connects with the pathophysiology of microcirculatory failure and organs dysfunction 
during sepsis, and inhibiting NOS activity can prevent vessel from dilating and then 
hypotension happens were proved (Hollenberg et al. 2000; L¨®pez et al. 2004; Avontuur et 
al. 1998; Evans et al. 1994; Nava, Palmer and Moncada 1992; Tracey, Tse and Carter 1995; 
Kilbourn et al. 1994; Laszlo, Whittle and Moncada 1994). However, several experimental 
studies also showed that inhibition of NO synthesis has no effect or might be harmful 
(Robertson et al. 1994). Recently years, scholars found that in a model of sepsis mice induced 
by CLP which is deficient in nNOS didn’t get the desired effect, in that they found out such 
mice had impaired bacterial clearance. Certainly, the survival rate also decreased. Ever more 
in wild-type mice under the regulation of a selective nNOS inhibitor had similar outcome. 
This suggested that nNOS wasn’t always harmful to sepsis, it may have a protective role 
(Cui et al. 2007). Moreover, mice with a cardiomyocyte-specific over expression of 
endothelial nitric oxide synthase (eNOS) was also partially protected against both 
endotoxemia and polymicrobial sepsis (Ichinose et al. 2006).Why does these phenomenon 
happen? Maybe a research team can give a reasonable answer. They found out NO at 
different concentration levels has different actions. Such diversity of cellular responses to 
NO as followings (Table 1) (Thomas et al. 2008).  
Generally, lower concentrations are good for cell survival and proliferation, and higher 
concentrations promote cell cycle arrest, senescence and apoptosis. As to the effects of UTI 
on NOS are still unknown. Chinese scholars discovered that UTI may through inhibiting the 
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activity of NF-κB to down-regulate the expression of iNOS mRNA within intestinal muscle 
to protect the intestinal motility in rats with bacterial peritonitis. However whether UTI can 
through regulating the activity of the NOS to act as protection on cardiac myocytes and if 
different dose of UTI has different effects are still poorly understood. 
 
NO concentrations Effects 
1 to 30 nM Physiological actions under the regulation of cyclic GMP-mediated 
processes predominate 
30 to 100 nM Tissue repair processes including AKT phosphorylation 
100 to 300 nM Hypoxia inducible factor-1 stabilization 
>1 μM Nitrosative stress 
Table 1. 
5.6 Inhibit releasing of sCD14 to act as protective action 
Soluble CD14 (sCD14), an endotoxin-related signal molecule, can enhance sensitivity of 
macrophage activation to endotoxin stimulation. In 1990, CD14 was recognized as a receptor 
for bacterial endotoxin (LPS) and it was the firstly described pattern-recognition receptor 
(Wright 1995). When combining with the conceptor TLR4, endotoxin-sCD14 complexes can 
lead to recruitment of IL-1–associated kinase under the endotoxin-induced, mediate nuclear 
factor (NF-κB) activation, then trigger the cytokine cascade. Evidence showed that sCD14 
expression can be induced by interleukin (IL)-6 in liver cells and it was recognized as acute 
phase protein (Anas, van der Poll and De Vos 2010). It was also the key mechanism of the 
pathogenesis for multiple organ failure (Rahman et al. 2004). In the rat model of acute 
necrotic pancreatitis, the level of sCD14 in rats treatment with hyperbaric oxygen and UTI 
group significantly decreases compare to the ones hyperbaric oxygen only used. Combined 
with the level of IL-6, TNF-ǂ and endotoxin, the author hold the opinion that UTI may 
decrease the level of sCD14 endotoxin related, and to function as inhibiting the pro-
inflammatory reaction and then enhance the immunity function (Hou et al. 2010). Last year, 
Japanese scholars K Shirakawa. et al (K Shirakawa et al. 2010) hold the opinion that sCD14-
ST may be the new sepsis marker. Thus UTI may through decreasing the level of sCD14 in 
blood to protect the heart tissue. But the reason is still unknown .  
5.7 Enhance express of HSP-70 to act as protective action 
Heat shock protein 70, which is conservative in organic evolution, was expressed 
constitutively in human erythroblasts that undergoes differentiation. It may suppress 
protein denaturation and keep the native conformation. It also acts as protective role in 
many physiological pathological and stress responses. Expression of HSP70 can be induced 
by fever, hypoxia, oxidative stress, endotoxin, cytokine, heavy metal ion and so on (Ribeil et 
al. 2007). Kustanova G. A. et al (Kustanova et al. 2006) found out the mortality of septic rat 
was decreased by supplying HSP-70 compare to control group. Another study suggested 
HSP-70 is closely associated with pulmonary biology, and has protective effects on lung 
injury, involves inhibition of NF-κB and pro-inflammatory gene expression. The 
mechanisms may concern that its anti-oxidation, anti-apoptosis, anti-inflammatory, stable 
transfection or molecular chaperone roles (Wheeler and Wong 2007). At the same time in 
animal experiments, Zhang, Z. et al (Zhang et al. 2010) found out the expression level of 
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HSP-70 in paraquat poisoning group under the treatment of UTI was higher than the control 
group. Then through associating the pathological section, they hold the opinion that UTI 
may regulate the expression of HSP-70 to increase the toxic tolerance and reduce lung 
injury. It was not reported that through up-regulation of HSP-70 in septic patients treated 
with UTI to increase the survival rate. However, based on the evidence above mentioned, 
we come out that UTI may has protective function of septic organs by up-regulating 
expression of HSP70.  
5.8 Inhibit expression of HMGB1 to act as protective action 
HMGB1, an intracellular protein, can translocate to the nucleus. It was originally described 
as a transcription factor which can bind DNA and regulate gene expression. HMGB1 is 
expressed by various cell types which contains a nucleus, such as macrophage, monocyte, 
neutrophil. The activating expression of HMGB1 may through non-transcriptional 
mechanisms and it is regulated by nuclear factor-κB (NF-κB) activation (Lotze and Tracey 
2005). During inflammation, causative agent and pro-inflammatory mediator (such as TNF-
a, IL-1b and IFNǄ) can induce expression of HMGB1. Of course interaction of complement 
C5a and its acceptor C5L2 can also promote the expression of HMGB1 (Lotze and Tracey 
2005). Signal transduction induced by HMGB1 is endowed with pleiotropic effects, that is 
pro-inflammatory and the role of potential damage to the endothelial barrier. Compare to 
other sepsis related cytokine, the peak level of HMGB1 occurs in the later stage and is 
regulated by autonomic nerves system(ANS) (Wang et al. 1999). Also a research found out 
that activation of the cholinergic anti-inflammatory pathway in sepsis can improve survival. 
The reason may be that this pathway can suppress macrophages secreting HMGB1 
(Rittirsch, Flierl and Ward 2008). In the septic rat model experiment, HMGB1 is significantly 
decreasing in UTI treatment group than control group. In this experiment also found out 
UTI can suppress the generation of O2-, TNF-a, IL-6, and lactic acidosis. Thus the author 
hold the opinion that UTI may be helpful for sepsis through regulating expression of 
HMGB1 (Koga et al. 2010). As to whether UTI can decrease the level of HMGB1 express by 
activation of the cholinergic anti-inflammatory pathway is worth doing deep research.  
5.9 Decrease the production of O2
-
 then reduce the activity of NF-κB to act on anti-
inflammatory effect 
Activiting of macrophage, neutrophils and reactive oxygen species (ROS) play an important 
in the pathophysiology of endotoxemia. Following activating of macrophage, neutrophils, 
NADPH oxidase is activated, leading to excessive ROS generation to kill the bacteria. Of 
course, one coin two sides, at the sometime ROS also injuries lung tissue and lead to 
breathlessness, and then enhance SIRS (Tanaka et al. 2010). Japanese scholars found out the 
level of O2-, HMGB1, TNF-a, IL-6 were lower in UTI treatment group than the control group 
(Tanaka et al. 2010). Previous studies had shown that the expression of HMGB1, TNF-a, IL-6 
was regulated by NF-κB. However NF-κB as a oxidation-reduction related sensitive 
transcription factor was under the regulation of ROS (Pahl 1999; Bar-Shai et al. 2008). It was 
known that UTI may through suppress the expression of HMGB1 (Koga et al. 2010), TNF-a 
(Cao et al. 2010), IL-6 (Park et al. 2010a) to act as anti-inflammatory. Thus they come up with 
the idea that anti-inflammatory of UTI may through reducing the production of O2- to 
decrease the activity of NF-κB for the first time. 
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5.10 As to regulating gene express of septic heart tissue under the UTI to act as 
protection  
Certainly in gene level, UTI treatment in sepsis was also make progress. An research team 
led by Inoue, K (Inoue et al. 2005) found out that the lung and kedney damage are serious in 
UTI-/- sepsis rats than control group. At the sometime IL-1ǃ, macrophage inflammatory 
protein (MIP)-1ǂ, MIP-2 and monocyte chemotactic protein (MCP)-1 are also higher than the 
control group. At last they come out that UTI may has important protection on sepsis. In 
additional, our previous study suggest UTI may regulate exaggerated or expression of 
inflammatory response related gene (Agt, Ace, IL6r) to protect the function of septic heart 
and kidney (Y Lin et al. 2011; Y Liu et al. 2010). 
5.11 At last UTI may also take important part in the energy metabolism during sepsis 
Evidence showed that the activation of Na+-K+-ATP enzyme is associated with balance of 
electrolyte. It was known that well activation of Na+-K+-ATP enzyme is very important in 
absorption of edema fluid. Thus protection of Na+-K+-ATP enzyme can reduce cellular 
edema and play an important part in keeping the stability of cell membrane. Researching 
found out activation of Na+-K+-ATP enzyme remarkable decrease in ischemia tissue, while it 
was not obvious in UTI pretreatment ones (Xiaoqiao et al. 2004). Moreover, Na+-K+-ATP -
ATPase and Ca2+-ATP-ATPase activity in UTI donor-pretreatment on liver graft group were 
higher than control group (Mao et al. 2011). In addition, a Japanese research team hold the 
opinion that UTI may maintain utilization of energy in the electron transfer system 
throughout the hypovolemic period and reperfusion and contributed to a rapid recovery of 
cardiac function after reperfusion, through reducing the damage of oxidative 
phosphorylation in mitochondria, even during hemorrhagic shock (Masuda et al. 2003). 
Those all suggest UTI may act as a protective role in organs of septic patients through 
maintaining the organs energy metabolism. 
6. Concluding remarks 
UTI may regulate the secretion of mediators of inflammation, related stress protein and 
related gene expression to release the inflammatory reaction, at the same time it can keep 
the activity of Na+-K+-ATP -ATPase to maintain the organs energy metabolism. It is derived 
from urine, as a endogenous anti-inflammatory drug, so it has little side effect and widely 
used in treatment of sepsis, acute pancreatitis, toxic shock, chronic pancreatitis. However, 
it’s as a immunomodulators may along with other drug to treat sepsis in order to improve 
the survival rate. 
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